Aspen Wealth Strategies’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Aspen Wealth Strategies's PFE Position: Q1 2026 in Review
Aspen Wealth Strategies increased its Pfizer (PFE) stake by 0.4% in Q1 2026, buying an estimated $1.09K and bringing the position to 10,261 shares worth $288K. The position accounts for 0.15% of the portfolio, ranked #76.
Aspen Wealth Strategies first reported a position in PFE in Q4 2022 and has held it in 14 quarters since. The position peaked at $616K in Q4 2022. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Aspen Wealth Strategies held 10,261 shares of Pfizer worth $288K as of Q1 2026.
- Aspen Wealth Strategies bought 41 Pfizer shares in Q1 2026, an estimated $1.09K.
- Pfizer made up 0.15% of Aspen Wealth Strategies's portfolio in Q1 2026, its #76 holding.
- Aspen Wealth Strategies first reported a position in Pfizer in Q4 2022 and has held it in 14 quarters since.
- Aspen Wealth Strategies's Pfizer position peaked at $616K in Q4 2022.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Aspen Wealth Strategies's 13F filing for Q1 2026, filed 8 May 2026.